What does a low serum transferrin level indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Low serum transferrin levels are a significant indicator of potential iron deficiency or impaired liver function, and clinicians should investigate underlying causes through additional tests. When evaluating low serum transferrin, it is essential to consider the patient's overall clinical context, including symptoms, medical history, and other laboratory results. Transferrin is a protein that transports iron in the bloodstream, and low levels can occur in conditions like liver disease, malnutrition, protein-losing enteropathy, or chronic inflammation 1. This finding may suggest impaired liver function, as the liver is the primary site of transferrin synthesis. Some key points to consider when interpreting low serum transferrin levels include:

  • Low transferrin often correlates with low serum iron and can contribute to anemia despite adequate iron stores, a condition known as anemia of chronic disease.
  • Transferrin saturation (the percentage of transferrin bound to iron) is often more informative than the absolute transferrin level alone, with a saturation of less than 16% among adults often used to confirm iron deficiency 1.
  • In patients with hypotransferrinemia due to a TF defect, transferrin supplementation by either plasma transfusion or apotransferrin infusion is recommended, along with monitoring of iron status to detect toxic iron loading early 1. Treatment should focus on addressing the underlying condition rather than directly supplementing transferrin, and monitoring transferrin levels can help track response to treatment of the primary disorder. In clinical practice, a comprehensive approach to diagnosing and managing low serum transferrin levels is crucial to ensure optimal patient outcomes, and this may involve collaboration with specialists such as hepatologists or hematologists.

From the Research

Low Serum Transferrin

  • Low serum transferrin can be an indicator of iron deficiency and anemia, as seen in patients with chronic kidney disease (CKD) 2.
  • Transferrin saturation, which is calculated by serum iron divided by total iron-binding capacity (TIBC), is also used to diagnose iron deficiency 3.
  • However, low serum transferrin can also be associated with other conditions, such as acute-on-chronic organ failure and short-term mortality in decompensated cirrhosis 4.
  • In patients with decompensated cirrhosis, low serum transferrin was found to correlate with the severity of organ failure, active alcoholism, and surrogates of systemic inflammation and macrophage activation 4.

Diagnosis and Treatment

  • Iron deficiency and iron deficiency anemia can be diagnosed based on decreased levels of serum ferritin and transferrin saturation 5.
  • Treatment for iron deficiency typically involves oral iron salts, but high-dose intravenous iron compounds are becoming increasingly popular, especially in cases where oral iron is not effective 6, 5.
  • The choice of treatment depends on the underlying cause of the iron deficiency and the patient's overall health status.

Prognostic Significance

  • Low serum transferrin has been found to be an independent predictor of short-term mortality in patients with decompensated cirrhosis 4.
  • In CKD patients, low serum iron and low transferrin saturation were associated with an increased risk of anemia, even in patients with normal transferrin saturation 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Low serum transferrin correlates with acute-on-chronic organ failure and indicates short-term mortality in decompensated cirrhosis.

Liver international : official journal of the International Association for the Study of the Liver, 2017

Research

Parenteral iron therapy options.

American journal of hematology, 2004

Related Questions

What are the diagnostic criteria for iron deficiency (ID) in the absence of anemia, the mechanisms by which it causes dyspnea, and the indications for intravenous (IV) iron infusion versus oral iron replacement therapy?
What does low transferrin (iron-binding protein) level indicate?
What is the diagnosis for a 61-year-old patient with a history of Diabetes Mellitus (DM), Hypertension (HTN), and a previous stroke, presenting with severe anemia, as indicated by a hemoglobin (Hgb) level of 7.97, mean corpuscular volume (MCV) of 94, mean corpuscular hemoglobin concentration (MCHC) of 31, hematocrit (HCT) of 25, total iron-binding capacity (TIBC) of 27, iron level of 9.3, ferritin level of 409, and vitamin B12 level of 1219?
What is the management approach for a patient with anemia, normal iron levels, low Total Iron Binding Capacity (TIBC), high iron saturation, and low transferrin levels?
What is the recommended regimen for parenteral iron therapy?
What is the likely diagnosis for a 24-year-old patient presenting with left-sided trigeminal neuralgia, episodic head shaking, blurred vision, and normal laboratory results for diabetes, thyroid function, and blood glucose levels?
Can the dosage of fluoxetine (Prozac) be increased from 20 milligrams to 40 milligrams?
What are the implications of a tear of the anterior talofibular ligament (ATFL) with a nondisplaced cuboid fracture?
What is the first line of treatment for excessive sweating (hyperhidrosis) in the hands and soles?
What are the causes of isolated hypertriglyceridemia (elevated triglycerides)?
Can the dosage of fluoxetine (Prozac) be increased from 20mg to 30mg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.